Abstract Details

Title Donepezil 23 mg/Day Improves Cognitive Abilities in Patients with Moderate-to-Severe Alzheimer's Disease: Evaluating the Impact on Language

Topic Aging and Dementia

Presentation(s) (-)

Poster/Presentation
Number 200

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Frederick A. Schmitt, PhD (University of Kentucky)	The institution of Dr. Schmitt has received research support from NIH.
Steven Ferris	No disclosure on file
Joan Mackell (Pfizer Inc)	No disclosure on file
Chad Hoyle, MD (Ohio State University)	Dr. Hoyle has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for National Football League. Dr. Hoyle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avexis. Dr. Hoyle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reata. The institution of Dr. Hoyle has received research support from REATA. The institution of Dr. Hoyle has received research support from TAKEDA.
Sharon Richardson, MD (Pfizer)	No disclosure on file
	No disclosure on file

��ɫ��